Aberdeen Asia Focus PLC reported a 22.3% net asset value total return for the year to 31 July 2026, well ahead of its small-cap Asian benchmark, in annual results published on 22 October. Shareholders now look to a presentation on 23 November and the Annual General Meeting on 7 December.

What happened

Aberdeen Asia Focus (LSE:AAS) is a constituent of the FTSE All-Share index and sits in the Association of Investment Companies' Asia Pacific Smaller Companies sector. There is no fresh results news today. The trust's most recent notices, on 2 November, were routine gearing and voting rights disclosures.

The 22 October report showed NAV per share rising to 460.05p from 381.72p, with net Assets of £630.2m. The benchmark, the currency-adjusted MSCI AC Asia ex Japan Small Cap Index, returned 9.5%. Over five years the NAV total return was 67.6%, against 37.8% for the index.

Taiwan Union Technology rose more than 270%, and Chroma ATE, Accton Technology and Precision Tsugami were also named among the leading contributors. NetEase Cloud Music, Yantai China Pet Foods, Classys, Affle 3i and Newgen Software held returns back.

Why it matters for investors

The first concern for holders is how much of this performance rests on one theme. The manager, Gabriel Sacks and Xin-Yao Ng, put AI-linked companies at about a quarter of the portfolio, and Taiwan was the largest country exposure at the year end. That helped in the period, but it is also a concentration worth watching in what is otherwise a diversified book of 67 holdings, where the top ten account for 27.8% of total assets.

The managers say they are recycling Capital into businesses with notable Earnings and reasonable valuations. They regard parts of India as expensive and see better value in China, Korea and Southeast Asia. New positions include DB Insurance, China Yuchai, WuXi XDC, Westports and Vietnam Dairy Products.

Governance has also moved. The first five-year performance-linked conditional tender test was passed, so no tender is required, and the mechanism has been renewed to 31 July 2031 on materially the same terms. In August the trust signed a three-year agreement with Saba Capital Management, under which Saba agreed not to seek board changes, requisition meetings, submit proposals or short the shares, among other restrictions. In our analysis, that reduces the near-term chance of a contested vote.

How the shares have performed

The shares delivered a 23.9% total return in the year, slightly ahead of NAV, and closed the period at 418.0p. The report cited a price of 435.0p at the time of writing. The discount was 9.1% at the year end, against 10.1% a year earlier.

Buybacks continued, though at a slower pace. The trust repurchased 9.4m shares, or 6.4% of its issued capital, compared with 17.9m a year before, adding about 0.5% to NAV.

Income is a modest part of the return. Dividends for the year total 6.44p, up from 6.43p, paid as four interims, which the report puts at a 1.5% Yield on the 435.0p price. Underlying earnings were 7.5p a share and Revenue reserves exceed 13.7p a share. The ordinary Dividend has been maintained or increased every year since 1998.

What to watch next

The online Shareholder presentation is set for 11am on 23 November, with the AGM following at 12.30pm on 7 December. The final Interim Dividend of 1.64p falls due in December.

Gearing is a further point to follow. Borrowing comprises £30m of 3.05% Loan notes maturing in 2035 and a revolving Credit Facility of up to £35m, with drawings raised by £7m to £32m in August. Weekly gearing disclosures, most recently on 2 November, will show how far the manager keeps leaning in.

The chair expects geopolitics, trade policy and rising bond yields to keep markets volatile, but wrote that "the Board remains confident of the Company's investment approach".